362 related articles for article (PubMed ID: 20694192)
1. Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.
do Nascimento GR; Barros YV; Wells AK; Khalil RA
Curr Hypertens Rev; 2009 Nov; 5(4):283-306. PubMed ID: 20694192
[TBL] [Abstract][Full Text] [Related]
2. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.
Khalil RA
Biochem Pharmacol; 2013 Dec; 86(12):1627-42. PubMed ID: 24099797
[TBL] [Abstract][Full Text] [Related]
3. Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.
Ross RL; Serock MR; Khalil RA
Curr Cardiol Rev; 2008 Nov; 4(4):309-22. PubMed ID: 20066139
[TBL] [Abstract][Full Text] [Related]
4. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause.
Serock MR; Wells AK; Khalil RA
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):165-86. PubMed ID: 18991792
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of estrogenic menopausal hormone therapy.
Reslan OM; Khalil RA
Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
[TBL] [Abstract][Full Text] [Related]
6. Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.
Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):29-46. PubMed ID: 20210774
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.
Smiley DA; Khalil RA
Curr Med Chem; 2009; 16(15):1863-87. PubMed ID: 19442151
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and vascular responses in hypertension and aging.
Qiao X; McConnell KR; Khalil RA
Gend Med; 2008; 5 Suppl A():S46-64. PubMed ID: 18395683
[TBL] [Abstract][Full Text] [Related]
9. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
10. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
11. Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease.
Khalil RA
Future Cardiol; 2007 May; 3(3):283-300. PubMed ID: 19804220
[TBL] [Abstract][Full Text] [Related]
12. Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.
Gencel VB; Benjamin MM; Bahou SN; Khalil RA
Mini Rev Med Chem; 2012 Feb; 12(2):149-74. PubMed ID: 22070687
[TBL] [Abstract][Full Text] [Related]
13. Sex hormones as potential modulators of vascular function in hypertension.
Khalil RA
Hypertension; 2005 Aug; 46(2):249-54. PubMed ID: 15983238
[TBL] [Abstract][Full Text] [Related]
14. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins.
Raffetto JD; Qiao X; Beauregard KG; Khalil RA
J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696
[TBL] [Abstract][Full Text] [Related]
16. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
Meyer MR; Barton M
Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular effects of selective estrogen receptor modulators.
Christodoulakos GE; Lambrinoudaki IV; Botsis DC
Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
[TBL] [Abstract][Full Text] [Related]
19. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators.
Kublickiene K; Svedas E; Landgren BM; Crisby M; Nahar N; Nisell H; Poston L
J Clin Endocrinol Metab; 2005 Nov; 90(11):6113-22. PubMed ID: 16131583
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific reduction in contraction is associated with increased estrogen receptor expression in single vascular smooth muscle cells of female rat.
Ma Y; Qiao X; Falone AE; Reslan OM; Sheppard SJ; Khalil RA
Cell Physiol Biochem; 2010; 26(3):457-70. PubMed ID: 20798531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
